<SEC-DOCUMENT>0002144542-26-000003-index.html : 20260807
<SEC-HEADER>0002144542-26-000003.hdr.sgml : 20260807
<ACCEPTANCE-DATETIME>20260807163342
ACCESSION NUMBER:		0002144542-26-000003
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20260801
FILED AS OF DATE:		20260807
DATE AS OF CHANGE:		20260807

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Kelly-Gemmell Dorothy Elizabeth
		CENTRAL INDEX KEY:			0002144542
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37355
		FILM NUMBER:		261254834

	MAIL ADDRESS:	
		STREET 1:		9920 PACIFIC HEIGHTS BLVD
		STREET 2:		SUITE 500
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Viking Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001607678
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				461073877
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		9920 PACIFIC HEIGHTS BLVD, SUITE 500
		CITY:			SAN DIEGO
		STATE:			CA
		BUSINESS PHONE:		858-704-4660

	MAIL ADDRESS:	
		STREET 1:		9920 PACIFIC HEIGHTS BLVD, SUITE 500
		CITY:			SAN DIEGO
		STATE:			CA
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>ownership.xml
<DESCRIPTION>3
<TEXT>
Document 1 - file: ownership.html

Document 1 - RAW XML: ownership.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>vktx-ex24.htm
<DESCRIPTION>EX-24
<TEXT>
Document 2 - file: vktx-ex24.htm

</DOCUMENT>
</SEC-DOCUMENT>